Clinical Trials Logo

Rheumatic Diseases clinical trials

View clinical trials related to Rheumatic Diseases.

Filter by:

NCT ID: NCT03306784 Recruiting - Clinical trials for Arthritis, Rheumatoid

Pain Catastrophizing and Routine Assessment of Patient Index Data 3(RAPID3) in Ten Categories of Rheumatology Outpatients

Start date: July 3, 2017
Phase: N/A
Study type: Observational

Fulfilling by all patients consequently seen by 6 rheumatologists in a same outpatient rheumatology clinic (in at least one month period) of a set of 6 questionnaires, including RAPID3 and pain catastrophizing scales.

NCT ID: NCT03293719 Not yet recruiting - Osteoarthritis Clinical Trials

Post-market Follow up Study of the 'BPK-S Integration' UC as Primary Implant in the Variants CoCr or Ceramic

Start date: December 1, 2017
Phase: N/A
Study type: Observational

Prospective Post-Market Clinical Follow up study according to MEDDEV 2.12/2 rev2 of the European Union. Patients receiving the primary knee implant BPK-S UC as primary implant in either variant ceramic or CoCr (metal) are eligible for the study and will be followed up for 5 years after implantation or until revision of the prosthesis, whichever occurs first. Demographic data will be collected together with data regarding safety and benefit at defined timepoints (preoperative, intraoperative and at 3 months, 1 year, 2 years and 5 years after implantation). Patients will be divided in 2 cohorts (ceramic and metal) and stratified by age.

NCT ID: NCT03281863 Not yet recruiting - Rheumatic Fever Clinical Trials

Clinical Audit on the Managment in Assiut University Children Hospital

Start date: October 1, 2017
Phase: N/A
Study type: Observational

clinical audit on the Managment of rheumatic fever in assiut university children hospital.

NCT ID: NCT03277703 Not yet recruiting - Clinical trials for Inflammatory Bowel Diseases

Flu Vaccine Response in Patients on Biologic Therapies

Start date: September 2017
Phase: Phase 2
Study type: Interventional

This proposed study will assess the immunogenicity, safety, and clinical efficacy of an influenza vaccine booster dose strategy in patients with autoimmune diseases who are receiving immunosuppressive therapies. Investigators will compare serologic responses to single versus a booster dose of influenza vaccine in patients with inflammatory bowel disease (IBD- Crohn's Disease or Ulcerative Colitis) or rheumatologic diseases who are receiving immunosuppressive therapies. Subjects will be randomized to receive either one or two doses of influenza vaccination in year #1. In year# 2, all participants will be given two doses of influenza vaccine. Serologic responses will be measured pre and 4-6 weeks post vaccination. This study will also assess the immunogenicity and safety of a booster vaccine strategy in the prevention of influenza-like illness (ILI). Investigators anticipate that booster dose strategy will improve both clinical and serologic responses in this vulnerable population.

NCT ID: NCT03272373 Recruiting - Clinical trials for Rheumatoid Arthritis

NexGen TM Tibia Clinical Outcomes Study

Start date: October 2017
Phase: N/A
Study type: Interventional

The objective of this study is to evaluate clinical performance for the commercially available NexGen TM Monoblock Tibia and NexGen TM Modular Tibia used in primary cementless tibia total knee arthroplasty.

NCT ID: NCT03268421 Not yet recruiting - Fibromyalgia Clinical Trials

Fibromyalgia Integrative Training for Adolescents With Juvenile Fibromyalgia

FIT Teens
Start date: October 2017
Phase: N/A
Study type: Interventional

This study evaluates whether Fibromyalgia Integrative Training program for Teens (FIT Teens), a combined cognitive behavioral therapy and neuromuscular exercise training program is more effective in reducing disability in adolescents with Juvenile Fibromyalgia compared to cognitive behavioral therapy (CBT) alone or a graded aerobic exercise (GAE) program alone. One third of participants will receive the FIT Teens training; one third will receive CBT training; and one third of participants will receive the GAE training.

NCT ID: NCT03257878 Recruiting - Clinical trials for Scleroderma, Systemic

Health-related Quality of Life in Korean Patients With Rheumatic Diseases

Start date: March 31, 2017
Phase: N/A
Study type: Observational

To compare the health related quality of life of patients with systemic sclerosis with other rheumatic diseases, such as rheumatoid arthritis, systemic lupus erythematosus and Sjogren's syndrome.

NCT ID: NCT03248518 Enrolling by invitation - Clinical trials for Rheumatoid Arthritis

Lessening the Impact of Fatigue in Inflammatory Rheumatic Diseases

LIFT
Start date: September 5, 2017
Phase: N/A
Study type: Interventional

Fatigue is common and disabling for most patients with inflammatory rheumatic disease. Therapies designed to improve physical activity and 'talking' treatments, which positively help patients change the way they think and behave, are both helpful in reducing the burden of the fatigue. However, few patients have access to these treatments in most health services. This situation results from the absence of standardised programmes and limited availability of relevant therapists. The investigators aim to enhance access to fatigue alleviating physical activity and talking therapies by testing innovative,standardised and cost-effective approaches to treatment delivery. The investigators will also use this opportunity to understand how to select the best treatment for a patient based on their individual profile and to better understand how these treatments actually work. This in turn may lead to more refined and effective therapies in the future.

NCT ID: NCT03245476 Not yet recruiting - Adhesive Capsulitis Clinical Trials

Education-based Physical Therapy Approach for Adhesive Capsulitis

Start date: September 4, 2017
Phase: N/A
Study type: Interventional

This study aims, by means of a randomized control trial, to investigate which treatment method (corticoid injection + physiotherapy with a focus on manual therapy and home-exercises versus corticosteroid injection + physiotherapy with focus on education and supported home exercises) gives better results on clinically relevant outcomes (range of glenohumeral motion, psychological factors, pain, shoulder function, quality of life) and on parameters derived from arthroscopic glenohumeral investigation by means of MRI. Furthermore, associations between (1) the results on the MRI investigation, (2) the range of glenohumeral motion, (3) shoulder function and pain, and (4) psychological factors will be assessed at different time-points (before and at 6-12-18 and 52 weeks after the first injection).

NCT ID: NCT03216616 Completed - Fatigue Clinical Trials

Guided Self-Management Intervention Targeting Fatigue in Rheumatic Inflammatory Diseases

Start date: September 2014
Phase: N/A
Study type: Interventional

Fatigue is common and debilitating in rheumatic inflammatory diseases as for other chronical medical conditions. The purpose of this study is to develope and evaluate a cognitive behavioural intervention targeting fatigue. The aim of the intervention is to improve fatigue self-management by changing behavioral and cognitive factors contributing to perceived fatigue. Levels of fatigue, depressive symptoms and self esteem will be measured before, after and three months after the intervention.